Introduction:

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic, sparking a worldwide crisis that has impacted every facet of society. As of May 15, 2020, nearly 4.35 million cases and 297,241 deaths have been reported globally. The repercussions extend beyond healthcare, with the pandemic triggering economic downturns, rising unemployment rates, and increased inflation. Amidst these challenges, companies are at the forefront of the battle, developing diagnostics and therapies to combat the virus.

Read Full Blog - https://meticulousblog.org/top-10-companies-in-covid-19-diagnostics-and-therapy-market

Top 10 Companies in COVID-19 Diagnostics and Therapy Market:

Roche Holding AG:

Global biotechnology leader.

Operates in Pharmaceuticals and Diagnostics segments.

Offers medicines and diagnostic products, with 97,735 employees globally.

Thermo Fisher Scientific, Inc.:

Engaged in scientific instrumentation, reagents, and consumables.

Operates in Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

AbbVie Corporation:

Research-based biopharmaceutical company.

Focuses on immunology, oncology, virology, and neuroscience.

Operates in over 75 countries, treating 30 million patients with 32 conditions.

Johnson & Johnson:

Multinational Corporation with three business segments.

Focuses on medical devices, pharmaceuticals, and consumer packaged goods.

Janssen Pharmaceutical, a subsidiary, is actively involved in COVID-19 vaccine development.

Moderna, Inc.:

Biotechnology company specializing in mRNA technology.

Strategic collaborations with AstraZeneca, Merck, and others.

Key player in drug discovery and development.

AstraZeneca Plc:

Global pharmaceutical and biopharmaceutical company.

Operates across eight therapeutic areas.

Active in research, development, production, and marketing.

Sorrento Therapeutics, Inc.:

Clinical stage biopharmaceutical company.

Focuses on treatments for cancer, inflammation, and autoimmune diseases.

Athersys, Inc.:

Research and development of novel therapies.

Advanced program includes MultiStem, a clinical stage allogeneic stem cell therapy.

Celularity, Inc.:

Clinical-stage cell therapeutics company.

Develops therapies for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration.

Takeda Pharmaceuticals Company LTD.:

Global biopharmaceutical firm.

Engaged in research, development, manufacture, and sale of pharmaceutical products.

Focuses on oncology, digestive system diseases, rare diseases, and neurology.

Popular Mentions:

Becton, Dickinson and Company
Abbott Laboratories
Danaher Corporation
Gilead Sciences, Inc.
Eli Lilly And Company
Novavax, Inc
GlaxoSmithKline (GSK)
Sanofi S.A.
Pfizer, Inc.
Cti Biopharma Corporation
Download Sample Copy for the Same - https://www.meticulousresearch.com/download-sample-report/cp_id=5098

Conclusion:

In the face of the COVID-19 pandemic, these companies are playing a pivotal role in developing diagnostics and therapies, contributing to the global fight against the virus. Their research, innovation, and strategic collaborations are instrumental in shaping the future of healthcare in these challenging times. Meticulous Research® provides a comprehensive report for those seeking in-depth insights into the COVID-19 Diagnostics and Therapy Market, covering financial performance, key products, company strategies, partnerships, and acquisitions.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research